On Apr 10, the Department of Labor released
Consumer Price Index (âCPIâ) data for the month of March. Although
inflation rose by the highest percentage point in 14 months, the
data was in line with the consensus estimate. Notably, core CPI, a
key inflation metric, came below expectation.
Tamed inflation together with a robust labor market has compelled
the Fed to continue with its dovish monetary stance. All these
positives are likely to bolster market rally. At this stage, it
will be prudent to invest in stocks with strong growth potential
and a favorable Zacks Rank.
Benign Inflation Data
The CPI for March came in at 0.4%, in line with the consensus
estimate. Year over year, the cost of living index increased 1.9%,
below the Fedâs target rate of 2%. However, core CPI â- the key
inflation metric, which excludes erratic price changes of food and
energy â- rose 0.1% in March, below the consensus estimate of 0.2%.
Year over year, core CPI declined to 2% compared with 2.1% in
February. This marks the smallest yearly increase in core CPI since
February 2018.
The last available data (released on Mar 29) for core personal
consumption expenditures (PCE) price index rose 0.1% in January,
less than the consensus estimate of an increase of 0.2%. The
year-over-year rise in the PCE pride index was 1.8%, below the 2%
target rate of the Fed. Notably, PCE price index is the Fedâs
most-favored inflation gauge.
Decline in Government Bond Yields and Dollar
Index
Following the release of March CPI data, yields on U.S. government
bonds have declined. The yield on benchmark 10-year Treasury Note
dropped 0.001% to 2.476%. Likewise, yields on long-term 30-Year
Treasury Note decreased 0.003% to 2.901%. Yields on short-term
2-Year Treasury Note stayed flat at 2.327. Similarly, yield
on 3-Month Treasury Note declined 0.001% to 2.426%.
Lower-than-expected inflation data also had an impact on the dollar
index. On Apr 10, the ICE U.S. Dollar Index (DXY), which measures
the greenbackâs strength against a basket of six major currencies,
decreased 0.02% to 96.93. Lower dollar price will make U.S. exports
more competitive in the international markets.
Fed Reiterates Dovish Monetary
Stance
On Apr 10, in its FOMC minutes, the Fed stated that the majority of
its members have decided to stick to the central bankâs March
decision of not hiking interest rate, signifying that the benchmark
interest rate will remain within its existing range of 2.25 â
2.5%.
The U.S. labor market remains robust. Unemployment rate is at its
50-year low level of 3.8%. Job data for March also revealed that
the average wage rate increased 0.14%. The wage rate increased 3.2%
year over year in March.
Despite a record-low unemployment level and rising nominal wage
rate, inflation remains within the target level of the central
bank. This compelled the Fed to stick to its stand of not raising
interest rate in 2019. A hike in interest may be considered at the
end of this year if U.S. economic fundaments improve.
Our Top Picks
The U.S. economy is likely to maintain its long-term growth albite
at a slow pace. Consequently, investment in stocks with strong
growth potential will be lucrative. Our selection is backed by a
Growth Score of A and a Zacks Rank #1 (Strong Buy). You can see the
complete list of todayâs Zacks #1 Rank stocks here.
The chart below shows price performance of our five picks in the
last three months.
SS&C Technologies Holdings
Inc. SSNC provides software products and software-enabled
services to financial services and healthcare industries in the
United States, Canada, Mexico, Europe, the Asia Pacific and Japan.
The company has an expected earnings growth rate of 30.5% for the
current year. The Zacks Consensus Estimate for the current year has
improved 7.3% over the last 60 days.
Insperity Inc. NSP provides human resources and
business solutions to enhance business performance for small and
medium-sized businesses in the United States. The company has an
expected earnings growth rate of 22.4% for the current year. The
Zacks Consensus Estimate for the current year has improved 6.5%
over the last 60 days.
MGP Ingredients Inc. MGPI produces and supplies
distilled spirits, and specialty wheat proteins and starch food
ingredients. The company has an expected earnings growth rate of
20.3% for the current year. The Zacks Consensus Estimate for the
current year has improved 6.5% over the last 60 days.
Medifast Inc. MED manufactures and distributes
weight loss, weight management, healthy living products, and other
consumable health and nutritional products. The company has an
expected earnings growth rate of 41.1% for the current year. The
Zacks Consensus Estimate for the current year has improved 11.5%
over the last 60 days.
Lululemon Athletica Inc. LULU designs and retails
athletic clothing for women, men and female youth. The company has
expected earnings growth of 20.3% for the current year. The Zacks
Consensus Estimate for the current year has improved 5% over the
last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit
Potential
The biotech sector is projected to surge beyond $775 billion by
2024 as scientists develop treatments for thousands of diseases.
Theyâre also finding ways to edit the human genome to literally
erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy
Right Now to help investors profit from 7 stocks poised for
outperformance. Our recent biotech recommendations have produced
gains of +98%, +119% and +164% in as little as 1 month. The stocks
in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free
report
SS&C Technologies
Holdings, Inc. (SSNC) : Free Stock Analysis Report
MGP Ingredients, Inc.
(MGPI) : Free Stock Analysis Report
MEDIFAST INC (MED) : Free
Stock Analysis Report
lululemon athletica inc.
(LULU) : Free Stock Analysis Report
Insperity, Inc. (NSP) :
Free Stock Analysis Report
To read this article on
Zacks.com click here.
Zacks Investment Research